Malaysian Re and China Re Life Sign Landmark Reinsurance Treaty for Cancer Precision Medicine Coverage

Malaysian Reinsurance Berhad (Malaysian Re) and China Reinsurance Life Insurance Company Limited (China Re Life) have signed a landmark reinsurance treaty supporting Cancer Precision Medicine (CPM) treatment coverage in Malaysia.

Beacon Global Risk Solutions Limited is honoured to have served as the appointed reinsurance broker for this milestone initiative, supporting the successful placement of the reinsurance arrangement.

This collaboration represents an important step in expanding access to innovative healthcare solutions while demonstrating the value of regional partnerships within the insurance and reinsurance industry.

To learn more about this initiative, please read the full press release published by Malaysian Re.

The information contained in this article is for general information and educational purposes only. It does not constitute financial, investment, or insurance advice. Beacon Global Risk Solutions Limited is licensed by the Labuan Financial Services Authority (Licence No. BS2025152) as a reinsurance and insurance broker. This content is intended for licensed insurance professionals and institutional parties.